| Literature DB >> 27822466 |
John J Wilson1, Janelle Grendler2, Azaline Dunlap-Smith3, Brian F Beal3, Shallee T Page3.
Abstract
Mya arenaria is a bivalve mollusk of commercial and economic importance, currently impacted by ocean warming, acidification, and invasive species. In order to inform studies on the growth of M. arenaria, we selected and inbred a population of soft-shell clams for a fast-growth phenotype. This population displayed significantly faster growth (p < 0.0001), as measured by 35.4% greater shell size. To assess the biological basis of this growth heterosis, we characterized the complete transcriptomes of six individuals and identified differentially expressed genes by RNAseq. Pathways differentially expressed included structural gene pathways. Also differentially expressed was the nucleotide-binding oligomerization domain 2 (NOD2) receptor pathway that contributes to determination of growth, immunity, apoptosis, and proliferation. NOD2 pathway members that were upregulated included a subset of isoforms of RIPK2 (mean 3.3-fold increase in expression), ERK/MAPK14 (3.8-fold), JNK/MAPK8 (4.1-fold), and NFκB (4.08-fold). These transcriptomes will be useful resources for both the aquaculture community and researchers with an interest in mollusks and growth heterosis.Entities:
Year: 2016 PMID: 27822466 PMCID: PMC5086354 DOI: 10.1155/2016/6720947
Source DB: PubMed Journal: Int J Genomics ISSN: 2314-436X Impact factor: 2.326
Figure 1Growth and survival of inbred line of M. arenaria. (a) Size, measured in shell length (SL) (in mm, open bars) and growth, measured as mean final SL (in mm, diagonally hatched bars) in the F3 versus F1 Mya arenaria. Error bars represent 95% CI ( p < 0.0001). Growth was 35.4% greater in the F3 versus F1 line. (b) Mean percent survival (open bars) in F3 versus F1 Mya arenaria. Mean percent survival was greater in the F3 versus F1 line by 126.4% ( p = 0.011).
Most highly ranked differentially expressed genes in FG clams, listing Bonferroni p value and fold-difference compared to WT.
| Gene name |
| Fold change in expression |
|---|---|---|
| Gamma receptor epsilon-like | 0 | 30.98 |
| Fatty acid synthase-like-1 | 0 | 22.1 |
| Fatty acid synthase-like-2 | 0 | 19.6 |
| Cyclin Y-like | 0 | 11.4 |
| Vesicle glycoprotein | 0 | 9.78 |
| Pathogenesis-related | 0 | 8.4 |
| Aryl hydrocarbon receptor-like | 0 | 8.3 |
| RISC component-like | 0 | 7.6 |
| Leukocyte member | 0 | 6.5 |
| Na/K ATPase | 0 | 6.3 |
| Insulin-like GF receptor | 0 | 6.1 |
| cAMP response binding protein | 0 | 5.7 |
| NaCl/amino acid transporter | 0 | 5.2 |
| Actin-binding protein | 0 | 5.1 |
| Na/K ATPase | 0 | 5.1 |
| O-glucanase-like | 0 | 4.6 |
| Amyloid beta-like | 0 | 4.4 |
| Solute carrier family 13-like | 0 | 4.3 |
| Cathepsin-like | 0 | 4.1 |
| Rho GTPase | 0 | 3.8 |
| Elongation factor 2 | 0 | 3.7 |
| Cold shock protein | 0 | 3.4 |
| Nuclear factor 1A | 0 | 2.7 |
| Tubulin alpha4a | 0 | 2.6 |
| Myosin heavy chain | 0 | −64.8 |
| Otoferlin-like | 5. | −42 |
| Actin 2 | 1. | −290 |
| Sarcoplasmic Calcium Binding Protein | 4. | −5 |
| Cytochrome P450 | 7. | −4 |
| Actin | 5. | −140 |
| Interferon alpha-inducible protein 27 | 5. | −19 |
| Exportin-1 | 2. | −21 |
| Troponin I | 1. | −6 |
| Myosin heavy chain | 1. | −9 |
| Fatty acid synthase-like | 2. | −45 |
| Low density lipoprotein receptor | 2. | −44 |
| Elongation factor 2 | 2. | −3 |
| Calmodulin | 3. | −21 |
| Alpha tubulin | 2. | −83 |
| Lysosome-associated membrane glycoprotein 1 | 5. | 1 |
| Fatty acid synthase | 1. | −3 |
| Transcriptional activator protein Pur-beta-like | 2. | −8 |
| Solute carrier family 13 | 5. | −34 |
| Lysosomal-associated transmembrane protein 4A-like | 6. | 7 |
| Bifunctional protein NCOAT-like | 7. | −12 |
| Far upstream element-binding protein 2-like | 1. | 19 |
| Bifunctional protein NCOAT-like | 3. | 5 |
| Patched domain-containing protein 3-like | 4. | −10 |
| Muscle blind-like protein 2-like | 9. | −6 |
| Beta-hexosaminidase-like | 1. | −28 |
| 40S ribosomal protein S2 | 1. | 7 |
| Farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like | 6. | 5 |
| Saposin-related protein | 7. | 6 |
| Chaoptin-like | 7. | 7 |
| Tubulin, alpha 1 | 9. | −24 |
Figure 2Categorization of differentially expressed genes from FG Mya arenaria. (a) Summary of identification of top 484 differentially expressed genes. (b) Summary of categories of Gene Ontology (GO) for the genes from (a) that were successfully annotated. List of 131 different genes identified were annotated with Gene Ontology biological process terms.
Figure 3Significantly differentially regulated genes in NOD2 Pathway. Genes significantly upregulated in the RNAseq screen (heavily outlined boxes). Post hoc analysis found notable differences in expression level in RIPK2 nine isoforms (five with average 3.3-fold increase, average p value 0.053, three isoforms ns, and one with 1.5-fold change), ERK/MAPK14 isoforms (one with 3.8-fold increase, p < 0.002, three ns), JNK/MAPK8 three isoforms (fold difference 4.1, p < 0.009, two other isoforms ns), and NFκB (fold difference 4.08, p < 0.04). The following showed no significant difference in expression level: ERBIN, iKKB, CASP8, TAK1, TRAF6, TRIP6, SGT1, and CARD6.
Figure 4Gene network analysis using STRING. A red line indicates the presence of fusion evidence; a green line indicates neighborhood evidence; a blue line indicates cooccurrence evidence; a purple line indicates experimental evidence; a yellow line indicates text-mining evidence; a light blue line indicates database evidence; a black line indicates coexpression evidence. Gene identification: A: Farnesyl diphosphate farnesyltransferase; B: Twitchin-like; C: Calmodulin; D: Myosin light chain; E: K14280 Exportin-like; F: PolyBC binding protein-like; G: Myosin heavy chain; H: Actin-related protein 1; I: Microtubule-associated monooxygenase- calponin- and LIM-domain-containing protein; J: Actin-related protein 2/3 (Arp 2/3); K: Actin-related protein 2a-like; L: Elongation factor-2-like; M: 40S ribosomal protein S2-like.